BDX

SELL

Becton, Dickinson and Company

Healthcare · Rank #275 · Analyzed Oct 18, 2026

$191.75

Current Price

$243.62

Intrinsic Value

+27.1%

Upside/Downside

2/10

Score

2/5

Quality

Analysis Summary

Valuation Consensus1/2 methods agree

Quality Score2/5.0

Framework RatingSELL

Price vs Intrinsic ValueUndervalued by 27.1%

Fair Value Range

Low$98.80

Base (IV)$243.62

High$315.64

Entry Points

Conservative$69.16

Moderate$98.80

Aggressive$170.54

Quality & Moat Breakdown

Return on Equity6.6% → 0/1.0

Debt LevelD/E 69 → 0/1.0

Revenue QualityGrowth 7.8%, margin Δ+0.7% +recovery → 1.0/1.0

Moat Strength2.5/5 → 0.5/1.0

Profit Margins4.2% → 0.5/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.